Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1181-1190 of 1,367) with videos related to

Pageof 137
Sort By:
Prehospital and Disaster Medicine|May 4, 2019
The Hennepin Ketamine Study Investigators' ReplyJeffrey D Ho, Jon B Cole, Lauren R Klein, et al.
Cell|March 3, 2023
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Journal of the American Chemical Society|August 28, 2024
Cu-Catalyzed Three-Component Alkene Carboamination: Mechanistic Insights and Rational Design to Overcome LimitationsTam D Ho, Byung Joo Lee, Travis L Buchanan, et al.
The Lancet. Oncology|April 11, 2008
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) studyMichael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
BMC Gastroenterology|October 6, 2010
Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based studyTung L Nguyen, Tomohisa Uchida, Yoshiyuki Tsukamoto, et al.
Frontiers in Immunology|September 19, 2022
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigensMatheus Oliveira de Souza, Bharat Madan, I-Ting Teng, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
Pageof 137

Showing results (1181-1190 of 1,367) with videos related to

Sort By:
Pageof 137
Prehospital and Disaster Medicine|May 4, 2019
The Hennepin Ketamine Study Investigators' ReplyJeffrey D Ho, Jon B Cole, Lauren R Klein, et al.
Cell|March 3, 2023
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Journal of the American Chemical Society|August 28, 2024
Cu-Catalyzed Three-Component Alkene Carboamination: Mechanistic Insights and Rational Design to Overcome LimitationsTam D Ho, Byung Joo Lee, Travis L Buchanan, et al.
The Lancet. Oncology|April 11, 2008
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) studyMichael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
BMC Gastroenterology|October 6, 2010
Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based studyTung L Nguyen, Tomohisa Uchida, Yoshiyuki Tsukamoto, et al.
Frontiers in Immunology|September 19, 2022
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigensMatheus Oliveira de Souza, Bharat Madan, I-Ting Teng, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
Pageof 137